Is this a PR piece paid for by Novartis, the makers of Canakinumab? Wikipedia says the drug costs $8k/week and the initial study showed no survival benefit. Then "further analysis" showed a big benefit. Something seems off.
No, the article isn't about this drug at all. It gets mentioned at the beginning, mostly. The rest talks about biology. The main takewaways for me, after having read it in its entirety, were:
* exercise regularly
* don't overeat
* ensure you're getting enough omega-3 (EDA and DHA,
from fish/fish oil/algae) and arachidonic acid
(beef/chicken/eggs)
https://en.wikipedia.org/wiki/Canakinumab